Anauxetic dysplasia is a rare genetic condition that causes very short stature and bone changes from early childhood. Features often include short limbs, a small chest, joint stiffness, and distinctive spine and pelvis findings. Growth differences are lifelong, and development in other areas may be typical. Care focuses on monitoring bones and breathing, physical therapy, and supportive treatments; there is no cure. Not everyone will have the same experience, and many people with anauxetic dysplasia live into adulthood with specialized care.
Overview
Anauxetic dysplasiaSymptoms
Anauxetic dysplasia features extremely short stature from birth and bone differences. Many have spine and chest changes, joint laxity, and limb bowing that can cause curvature or breathing issues. Growth remains markedly limited, though development and learning are usually intact.
Outlook and prognosis
Most people with Anauxetic dysplasia live into adulthood, though short stature and spine or joint issues often need lifelong care. Early, team-based management helps protect mobility, breathing, and heart health. Regular follow‑up supports school, work, and everyday independence.
Causes and risk factors
Anauxetic dysplasia results from harmful changes in the RMRP gene, present before birth and inherited when both parents carry a nonworking gene. Risk is higher with carrier parents, family history, or parental relatedness; no lifestyle or environmental causes are known.
Genetic influences
Genetics are central in Anauxetic dysplasia. It’s caused by inherited changes in genes that control bone growth, usually passed in an autosomal recessive pattern, so both parents often carry a variant. Genetic testing confirms diagnosis and guides family planning.
Diagnosis
Doctors suspect anauxetic dysplasia from clinical features and characteristic bone changes on X-rays. Confirmation usually comes from genetic tests. A specialist team coordinates imaging, growth assessment, and the genetic diagnosis of anauxetic dysplasia.
Treatment and drugs
Treatment for anauxetic dysplasia focuses on supportive, coordinated care. Teams often tailor plans with growth and bone-strength monitoring, physical therapy, mobility aids, fracture prevention, dental and eye care, and surgeries for spine or limb alignment when needed. Genetic counseling and long‑term follow‑up help guide decisions.
Symptoms
Living with Anauxetic dysplasia often means very short height and bone differences that can affect movement, posture, and comfort. The early features of Anauxetic dysplasia are usually noticed in infancy or even before birth, most often involving the spine and limb bones. Symptoms vary from person to person and can change over time. Many people have typical learning and development but may need tailored supports for mobility and daily tasks.
Very short height is present from early infancy and becomes more obvious with age. In Anauxetic dysplasia, both the trunk and limbs are short compared with peers. This can make reaching, transfers, and seating adaptations important.
The spine may curve forward or sideways. This can cause back pain, tiredness with sitting or walking, and a visible hunch or lean. Bracing or surgery may be considered if the curve progresses.
The top of the neck may be less stable because a small bone at the base of the skull is underdeveloped. Clinicians call this atlantoaxial instability, which means extra movement between the first two neck bones. It can lead to neck pain, headaches, or tingling in the arms and needs careful protection during activities and anesthesia.
The channel for the spinal cord can be smaller than usual in Anauxetic dysplasia. This may show up as leg pain, numbness, or weakness, especially with walking. In severe cases, balance or bladder control can change.
How people usually first notice Anauxetic dysplasia?
Parents and doctors often spot the first signs of Anauxetic dysplasia shortly after birth or in early infancy, when growth is markedly below expectations despite good feeding and care. Many notice distinctive skeletal features—very short limbs compared with the trunk, a relatively large head, and facial features like a prominent forehead—prompting early X-rays that reveal characteristic bone changes. In practice, this is how Anauxetic dysplasia is first noticed: pronounced, disproportionate short stature emerging in the first months of life, followed by radiographic findings that confirm a skeletal dysplasia.
Types of Anauxetic dysplasia
Anauxetic dysplasia is a rare genetic skeletal condition with a few recognized clinical variants described in the medical literature. These variants are usually defined by which gene is affected and can differ in bone findings, growth pattern, and involvement of other systems like teeth or nails. Not everyone will experience every feature, and severity can range from mild to more pronounced. When people look up types of Anauxetic dysplasia, they’re generally referring to these gene-based variants and how their symptoms differ.
RNU4ATAC-related
This classic variant involves changes in a small nuclear RNA gene that disrupts bone growth and leads to severe, early-onset short stature. People often have distinctive spine and hip findings, with possible dental and nail changes.
POP1-related
This rarer variant affects a gene involved in RNA processing and tends to cause significant short stature with skeletal differences that may partly overlap the RNU4ATAC form. Some may have milder or different facial and dental features.
Severity spectrum
Across variants, height is markedly below average, and spine and pelvic bones are commonly affected. The balance of symptoms can shift over time, with some people showing more dental or nail involvement than others.
What genetics can tell you about symptoms
Some people with anauxetic dysplasia have extreme short stature from birth, spine and hip changes, and early joint stiffness because variants in the RBM8A or other growth‐plate genes disrupt how cartilage cells mature. These genetic changes also link to small chest size, bowed legs, and delayed bone age.
Causes and risk factors
Anauxetic dysplasia is caused by a gene change present from birth. It usually occurs when both copies of the same gene have a change, often inherited from healthy carrier parents. Risk factors for Anauxetic dysplasia include a family history, parents who are both carriers, and parents who are related by blood. Lifestyle or environment do not cause it, but good nutrition, bone-friendly activity, and infection prevention may shape day-to-day health. Doctors distinguish between risk factors you can change and those you can’t.
Environmental and biological risk factors
Anauxetic dysplasia raises understandable questions about early symptoms of Anauxetic dysplasia and about what in pregnancy or the environment might affect the chance of it occurring. Doctors often group risks into internal (biological) and external (environmental). For this condition, research to date has not identified clear environmental triggers, and most outside exposures studied have not shown a link. We’ll focus on what is known about environmental and biological risks.
No specific outside exposure has been shown to raise the chance of Anauxetic dysplasia. Studies have not linked everyday air pollution, household products, or workplace agents to higher risk.
Older maternal or paternal age has not shown a consistent connection with Anauxetic dysplasia. Current data do not support a meaningful change in risk with parent age.
Conditions like preexisting diabetes or thyroid disease can affect pregnancy. They have not been shown to increase the likelihood of this condition.
Certain viral infections during pregnancy can lead to birth problems. None have been shown to raise the likelihood of this condition.
Genetic risk factors
Most cases trace to inherited changes in genes that guide bone growth. The genetic causes of anauxetic dysplasia most often involve the RMRP gene or the POP1 gene, which both support the same cell process. These changes are passed in an autosomal recessive way, meaning a child is affected only when both parents carry one nonworking copy. People with the same risk factor can have very different experiences.
RMRP variants: Changes in the RMRP gene are a well-known cause of anauxetic dysplasia. They reduce how well certain cells in the growth plate multiply and mature. This disrupts normal bone growth from early development.
POP1 variants: Faults in the POP1 gene can also cause anauxetic dysplasia. POP1 works with RMRP in the same cellular process, so similar changes in growth result. Different POP1 changes may lead to a range of severity.
Autosomal recessive: A child is affected when they inherit one nonworking copy of the gene from each parent. With each pregnancy, the chance of an affected child is 25% (1 in 4). This pattern affects all sexes equally.
Carrier parents: Parents who each carry one changed copy typically have no symptoms. When both are carriers of the same gene change, they have a higher chance of having an affected child. Carrier testing can identify this risk before or during pregnancy.
Parental relatedness: When parents are closely related, they are more likely to carry the same rare gene change. This raises the chance of a child inheriting two nonworking copies. This genetic risk applies across regions and communities.
Affected sibling: Having one child with anauxetic dysplasia means future children have the same 25% (1 in 4) chance if both parents are carriers. Genetic counseling can clarify options for family planning.
Founder variants: In some families or populations, a specific long-standing gene change is more common. This can make anauxetic dysplasia appear more often in those groups than expected. Testing can look for these known changes first.
Variant type: Different changes in RMRP or POP1 can leave different amounts of gene function. This helps explain why severity can vary. Lab reports often describe whether a change clearly disrupts function.
Genetic testing: Sequencing and targeted tests can look for changes in RMRP and POP1 to confirm the diagnosis. A confirmed result pinpoints the genetic causes of anauxetic dysplasia and refines recurrence risk for relatives. Testing can also identify unaffected carriers in the family.
Lifestyle risk factors
Lifestyle habits do not cause Anauxetic dysplasia, but daily choices can influence pain, spinal stability, breathing, and fracture risk. Focusing on safe movement, joint protection, and bone health can reduce complications and support independence. A tailored plan from therapists is essential, yet understanding how lifestyle affects Anauxetic dysplasia helps guide day‑to‑day decisions.
Swimming, cycling, and water therapy maintain muscle and joint mobility without pounding the spine. These choices lower vertebral compression risk and ease daily movement.
Contact sports, trampolines, and heavy lifting can worsen vertebral compression and joint deformities in Anauxetic dysplasia. Choosing gentler activities helps protect the spine and hips.
Gentle core and back exercises improve trunk support for unstable or misshapen vertebrae. Better spinal support may reduce pain and fatigue during standing and walking.
Slow, controlled stretching preserves range of motion without stressing lax joints. Avoid forceful spinal bending to prevent worsening kyphosis or back pain.
Risk prevention
Anauxetic dysplasia is a rare genetic condition, so you can’t prevent the condition itself, but you can lower the chance of complications and protect long‑term health. Even if you can’t remove all risks, prevention can reduce their impact. Early symptoms of anauxetic dysplasia often appear in infancy, so building a care plan early can help with breathing, mobility, and day‑to‑day comfort. Most strategies focus on infection prevention, spine and airway safety, and regular monitoring.
Carrier testing and family planning can clarify your chances of having a child with anauxetic dysplasia. Options may include prenatal testing or IVF with embryo testing, depending on local laws and personal preferences.
Keeping routine vaccines up to date, including flu and pneumonia shots, lowers infection risk. Good handwashing and quick care for fevers or coughs can prevent small infections from becoming serious.
Screening for snoring, pauses in breathing, or restless sleep can catch sleep apnea early. Treatments like tonsil/adenoid care or CPAP may ease breathing and protect the heart and brain overnight.
Regular checks for cervical spine instability and scoliosis help prevent nerve or cord problems. Avoid high‑impact or contact sports, and use careful neck positioning during travel and medical procedures.
Transmission
Anauxetic dysplasia is not infectious; it can’t be caught or spread through contact, saliva, or air. The genetic transmission of Anauxetic dysplasia is autosomal recessive, meaning both parents typically carry one nonworking copy of the gene but have no symptoms. When two carriers have a baby, each pregnancy has a 25% chance the child will have anauxetic dysplasia, a 50% chance the child will be a carrier like the parents, and a 25% chance the child will inherit neither copy. Families often first learn about carrier status when a child is diagnosed, and carrier or prenatal testing may be available for relatives.
When to test your genes
Test your genes if you or your child have very short stature from infancy with disproportionate body features, or if a close relative is diagnosed with anauxetic dysplasia. Genetic testing confirms the diagnosis, guides care, and informs family planning. A genetics referral is appropriate at any age when these signs are present.
Diagnosis
Anauxetic dysplasia is usually recognized by its pattern of very limited growth and specific bone changes seen from early life. The genetic diagnosis of Anauxetic dysplasia is confirmed by finding changes in the RNU4ATAC gene, often through a panel or exome test. Family history is often a key part of the diagnostic conversation. Imaging and exam findings guide which genetic tests are most helpful.
Doctors look for severe, proportionate short stature present before and after birth, along with skeletal differences affecting the spine, hips, and limbs. These clinical clues help focus testing toward skeletal dysplasias like Anauxetic dysplasia. Careful measurement of height, limb proportions, and joint mobility supports the clinical impression.
X‑rays of the spine, pelvis, hands, and long bones look for a consistent pattern of bone changes. These imaging findings help distinguish Anauxetic dysplasia from other forms of primordial dwarfism and skeletal dysplasia. Radiographic patterns across multiple bones are more informative than a single image.
A genetics lab analyzes the RNU4ATAC gene for disease‑causing changes, often as part of a skeletal dysplasia panel or whole‑exome sequencing. Identifying two pathogenic variants confirms Anauxetic dysplasia in most families. If panel testing is negative, broader sequencing may still find the cause.
During pregnancy, ultrasound may show very small fetal size and shortened bones earlier than expected. These findings raise suspicion and prompt planning for postnatal evaluation for Anauxetic dysplasia. Genetic testing of the baby or, in some cases, prenatal testing can provide confirmation.
Stages of Anauxetic dysplasia
Anauxetic dysplasia does not have defined progression stages. It’s a rare, lifelong skeletal condition present from birth, and while features can change over time, they don’t follow a uniform step-by-step pattern. Different tests may be suggested to help confirm the diagnosis, often combining a physical exam, bone X-rays, growth measurements, and sometimes a genetic test of the RMRP gene. Monitoring usually focuses on growth, spine shape, breathing, and joint function, and may be prompted when early symptoms of anauxetic dysplasia—such as very short length in infancy or unusual bone proportions—are noticed.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Anauxetic dysplasia, height remains very short and bones stay fragile, which can shape everyday choices like using step stools, mobility aids, or modified seating. Joint stiffness, spinal curvature, and early wear-and-tear can lead to pain or fatigue after routine tasks. Respiratory issues may appear if the chest is very small, and crowding of teeth or a narrow airway can affect sleep. Many people ask, “What does this mean for my future?”, and the answer depends on which features are most pronounced—growth, spine and hip stability, and breathing support tend to matter most.
Doctors call this the prognosis—a medical word for likely outcomes. Most children and adults with Anauxetic dysplasia can live into adulthood, especially with careful monitoring of the spine, hips, airway, and teeth. Serious complications are more likely when there is severe spinal instability, pronounced chest restriction, or repeated breathing problems; these can raise health risks and, in rare cases, affect life expectancy. Early symptoms of Anauxetic dysplasia that need attention include slow growth with very short stature, neck or back pain, frequent falls, or signs of sleep-disordered breathing like loud snoring or pauses in breathing at night.
Everyone’s journey looks a little different. With coordinated care—orthopedics, pulmonology, dentistry, physical therapy, and genetics—many people maintain independence at school, work, and home. Growth hormone does not change final height in this condition, but bracing, carefully planned surgeries, and tailored therapy can protect mobility and reduce pain. Talk with your doctor about what your personal outlook might look like, including plans for regular imaging of the neck and spine, sleep testing if symptoms point to airway narrowing, and practical supports that keep daily life safe and active.
Long-term effects
Anauxetic dysplasia is a rare genetic skeletal condition that mainly affects growth and bone shape over a lifetime. Many people notice early symptoms of Anauxetic dysplasia in infancy—such as very slow growth and unusual bone proportions—which tend to continue into adulthood. Long-term effects vary widely, but most relate to height, spine and chest structure, joint function, and day-to-day mobility. Outlook depends on how the skeleton and breathing are affected over time rather than on learning or mood, which are often typical.
Height remains far below age peers throughout life. Body proportions may look different, with shorter limbs or trunk depending on which bones are most affected. This is a lifelong feature rather than a phase.
Scoliosis or kyphosis can develop or gradually increase over time. Changes in the spine may affect posture and comfort. In some, this also influences lung space.
A narrow or misshapen chest can limit breathing capacity. Some may experience shortness of breath with activity or during respiratory infections. The impact can range from mild to more noticeable over time.
Bowed legs, knock knees, or turned-in feet can persist. These alignment differences may shift body mechanics and balance. Over years, they can add strain to hips, knees, or ankles.
How is it to live with Anauxetic dysplasia?
Daily life with anauxetic dysplasia often revolves around practical adaptations for very short stature and joint stiffness—things like step stools, customized seating, reachable storage, and mobility aids for longer distances. Many find school, work, and public spaces easier with early planning: accessible transportation, tailored physical therapy, and clinicians who understand bone fragility and airway or spine considerations. Family, friends, and coworkers may need guidance on how to offer support that respects independence—simple adjustments, patient pacing, and avoiding lifting or pulling that could strain joints often help. Emotionally, connection with others living with rare skeletal conditions, clear care plans, and celebrating autonomy can turn daily challenges into manageable routines.
Treatment and drugs
Treatment for anauxetic dysplasia focuses on managing symptoms and supporting growth, bone health, and mobility, since there’s currently no therapy that changes the underlying condition. Care often includes coordinated care with orthopedics, endocrinology, physiotherapy, dentistry, and audiology to address short stature, spine and limb alignment, joint stiffness, dental enamel issues, and hearing concerns. Supportive care can make a real difference in how you feel day to day, such as physical therapy to maintain flexibility and strength, braces or custom footwear for alignment, and pain management when needed. Growth hormone has not been proven to increase height in anauxetic dysplasia, and surgery is considered case by case for significant deformities or spinal problems, balancing potential benefits with risks. Ask your doctor about the best starting point for you, and plan regular check-ins so treatments can be adjusted as needs change over time.
Non-drug treatment
Living with Anauxetic dysplasia often means navigating short stature, joint laxity, and spine or limb differences that affect daily tasks like walking, dressing, and reaching. Care focuses on protecting mobility, easing pain, and supporting breathing, hearing, dental health, and independence at home and school. Non-drug treatments often lay the foundation for long-term function and comfort. Early symptoms of Anauxetic dysplasia—like delayed motor milestones or frequent falls—can guide which supports to put in place first.
Targeted exercises build core and hip strength to support loose joints and protect the spine. Gentle range-of-motion and balance work help mobility while limiting strain. High-impact activities are usually replaced with low-impact options like swimming.
Skill-building and energy-conservation techniques make dressing, bathing, and school or work tasks easier. Home and classroom adaptations support independence and reduce fatigue.
Custom braces or orthotics can steady ankles, knees, or wrists and improve alignment. Spinal bracing may be considered to slow curve progression and support posture.
Mobility aids, step stools with rails, and reachers help with safe walking and daily tasks. Adaptive seating and height-adjustable surfaces reduce strain and support comfort.
Your genes may have an impact on how drugs work for you
When treating anauxetic dysplasia, responses to pain control, bone health support, and anesthesia can vary because enzymes that process drugs are partly set by your genes. Genetic differences may change how fast medicines are cleared, effective doses, and side‑effect risk.
Pharmacological treatments
Anauxetic dysplasia has no approved disease‑modifying drug, so medicines focus on symptoms and complications. Drugs that target symptoms directly are called symptomatic treatments. While medicines don’t change early symptoms of anauxetic dysplasia, they can ease pain, protect bone health, and treat infections when they arise. Plans are individualized and typically guided by a metabolic bone or pediatric specialist.
Acetaminophen (paracetamol) or ibuprofen can reduce day‑to‑day joint or back pain. For people with anauxetic dysplasia, use the lowest effective dose and avoid NSAIDs like ibuprofen or naproxen if there are kidney, stomach, or bleeding risks.
Gabapentin or pregabalin may be used if nerve compression causes burning or shooting pain. Start low and increase slowly to limit dizziness or sleepiness. Dosing may be increased or lowered gradually to balance relief and side effects.
Cholecalciferol (vitamin D3) and calcium are used when tests show low levels or poor intake. Some living with anauxetic dysplasia may need supplements based on labs and diet. Regular blood checks help avoid too‑high calcium and guide dosing.
In confirmed low bone density or cluster fractures, specialists may consider pamidronate or zoledronic acid. Evidence is limited in anauxetic dysplasia, so decisions are individualized. These intravenous drugs are given intermittently and require monitoring of calcium, kidneys, and dental health.
Genetic influences
This condition is driven by inherited changes in genes that guide early bone and cartilage growth. Most people with anauxetic dysplasia have two gene changes—one from each parent—most often in the RMRP gene and, less commonly, in the POP1 gene. This pattern is called autosomal recessive inheritance: when both parents are healthy carriers, each pregnancy has a 25% (1 in 4) chance of a child with anauxetic dysplasia, a 50% (1 in 2) chance of a carrier, and a 25% chance of neither. A “carrier” means you hold the gene change but may not show symptoms. Even within the same family and with the same gene change, features can vary, and related conditions in the same gene (such as cartilage-hair hypoplasia) can look different from anauxetic dysplasia. Genetic testing can confirm the cause and clarify risks for relatives, which is especially helpful when early symptoms of anauxetic dysplasia are noticed in a newborn.
Is Anauxetic dysplasia genetic?
Genetics are central in Anauxetic dysplasia. It’s caused by inherited changes in genes that control bone growth, usually passed in an autosomal recessive pattern, so both parents often carry a variant. Genetic testing confirms diagnosis and guides family planning.
Pharmacogenetics—how genetics influence drug effects
Genetics can influence not only the condition itself, but also how certain medicines work during care. In Anauxetic dysplasia, the gene change that drives the bone growth problem doesn’t by itself predict response to most drugs, but other common drug processing genes can. These differences may affect pain medicines such as codeine or tramadol, some anti-inflammatory drugs, and medicines used for sedation or anesthesia during imaging and orthopedic procedures that many people with Anauxetic dysplasia need. Alongside medical history and current treatments, genetic testing can sometimes identify how your body handles specific drugs so dosing is safer and more effective. For example, some people break down codeine very slowly and have more side effects, while others activate and clear it quickly and feel little pain relief—two patterns that call for different choices or doses. Genes are only one piece of drug response in Anauxetic dysplasia; age, small body size, airway and spine features, and liver or kidney function also matter, so your team will tailor medicines with all of this in mind.
Interactions with other conditions
Breathing and spine issues can interact with other illnesses in day-to-day life for people living with Anauxetic dysplasia. Doctors call it a “comorbidity” when two conditions occur together. Respiratory infections or colds can worsen narrow airways and a small chest, making coughing and sleep apnea harder to manage, and even mild dehydration or sedation from medicines can increase the risk of breathing pauses at night. Ear, nose, and throat problems—like frequent ear infections or enlarged tonsils—may add to hearing or sleep concerns, while dental crowding can complicate oral health if gum disease is present. Some people within the same family of conditions have immune system differences, so when evaluating early symptoms of Anauxetic dysplasia, clinicians often check for unusual or severe infections that might signal overlapping issues. Spine narrowing or joint problems can also interact with other diseases by increasing the risk of nerve symptoms during growth spurts, infections, or surgeries, which is why coordinated care around anesthesia, airway support, and infection prevention is especially important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who stayed unusually small, with short limbs and a sturdy build, yet sharp minds and lively personalities. Families might recall a grandparent who “never outgrew the child-size coat,” or cousins who shared the same compact frame generation after generation. These everyday notes, passed along in families and clinics, set the stage for recognizing Anauxetic dysplasia as a distinct condition.
First described in the medical literature as a form of severe, proportionally short stature with very slow growth, Anauxetic dysplasia drew attention because growth seemed to stall early, far below typical height curves. Early case reports focused on what clinicians could see: very short height, small chest, and characteristic bone shapes on X‑rays, often with delayed bone age. At the time, the emphasis was on pattern recognition—lining up similar stories and images to decide whether these children shared the same diagnosis.
Over time, descriptions became clearer as specialists in bone disorders compared notes and built registries. Radiology helped define recognizable features in the spine and long bones, and careful exams documented how head size, facial shape, and joint mobility varied. Not every early description was complete, yet together they built the foundation of today’s knowledge. As more families were identified, it became clear that Anauxetic dysplasia was not simply “short stature,” but a specific skeletal dysplasia with its own tempo and traits.
Advances in genetics shifted the story from observation to cause. Researchers linked Anauxetic dysplasia to changes in a gene that helps regulate how cartilage cells in the growth plates mature and stack—a process that acts like a dimmer switch for bone growth. This discovery explained why growth slows so dramatically and why X‑rays show a consistent pattern, even when people’s day‑to‑day abilities differ. Genetic testing also clarified inheritance in many families, confirming when a condition ran through generations and when it appeared for the first time.
In recent decades, awareness has grown as pediatricians, geneticists, and radiologists have shared guidance on recognizing the early symptoms of Anauxetic dysplasia and distinguishing it from other causes of short stature. With this shared knowledge, children are more likely to receive earlier evaluations, coordinated care, and genetic counseling for their families. The history of Anauxetic dysplasia reflects a broader arc in medicine: careful observation leading to clearer definitions, then to understanding the biology behind them, and, ultimately, to more informed care for people living with this rare form of skeletal dysplasia.